These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2001175)

  • 1. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
    Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
    Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
    Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
    Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1.
    Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K
    Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 (HIV-1) superinfection of a cell clone converting it from production of defective to infectious HIV-1 is mediated predominantly by CD4 regions other than the major binding site for HIV-1 glycoproteins.
    Ohki K; Kishi M; Ohmura K; Morikawa Y; Jones IM; Azuma I; Ikuta K
    J Gen Virol; 1992 Jul; 73 ( Pt 7)():1761-72. PubMed ID: 1629701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
    Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M
    Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    Aiken C; Trono D
    J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of virus-like particles produced by SIV-chronically infected human cell clones.
    Kraiselburd EN; Torres JV
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S41-52. PubMed ID: 8574147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.
    Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S
    Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
    Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone.
    Imai H; Maotani-Imai K; Shin YS; Ikuta K; Suehiro S; Kurimura T; Kato S; Hirai K
    Virus Genes; 1991 Jan; 5(1):81-8. PubMed ID: 2017879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    Dedera D; Ratner L
    J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
    Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.
    Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P
    J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein.
    Ratner L; Vander Heyden N; Garcia J; Polinsky M; Westervelt P; Becich M
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):287-94. PubMed ID: 1829617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).
    Reitz MS; Hall L; Robert-Guroff M; Lautenberger J; Hahn BM; Shaw GM; Kong LI; Weiss SH; Waters D; Gallo RC
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1143-55. PubMed ID: 7826699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells.
    Boulerice F; Li XG; Lvovich A; Wainberg MA
    J Virol; 1991 Oct; 65(10):5589-92. PubMed ID: 1895407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.